MY137139A - Formation of tissue engineered human skin using hpd as biomaterials - Google Patents
Formation of tissue engineered human skin using hpd as biomaterialsInfo
- Publication number
- MY137139A MY137139A MYPI20042556A MYPI20042556A MY137139A MY 137139 A MY137139 A MY 137139A MY PI20042556 A MYPI20042556 A MY PI20042556A MY PI20042556 A MYPI20042556 A MY PI20042556A MY 137139 A MY137139 A MY 137139A
- Authority
- MY
- Malaysia
- Prior art keywords
- skin
- tissue engineered
- hpd
- biomaterials
- formation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
- A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
- C12N5/0698—Skin equivalents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
- C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1323—Adult fibroblasts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A CULTURED RECONSTRUCTIVE SKIN OR A TISSUE ENGINEERED SKIN IS INVENTED THROUGH THE TECHNIQUE OF PRODUCING AUTOLOGOUS BILAYER HUMAN SKIN USING HUMAN KERATINOCYTES AND DERMAL FIBROBLASTS CULTURED FROM A SMALL SAMPLE OF PATIENT SKIN BY MIXING IT WITH HUMAN PLASMA DERIVATIVES 9HPD). THIS TISSUE ENGINEERED SKIN IS VERY USEFUL IN THE TREATMENT OF BURN PATIENT, CHRONIC DIABETIC ULCER, PRESSURE ULCERS E.G.: BEDSORES, SKIN DISORDERS, IN RECONSTRUCTIVE SURGERY AND FOR PLASTIC SURGERY OR ANY OTHER SIMILAR USAGES.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20042556A MY137139A (en) | 2004-06-29 | 2004-06-29 | Formation of tissue engineered human skin using hpd as biomaterials |
PCT/SG2005/000208 WO2006001778A1 (en) | 2004-06-29 | 2005-06-24 | Formation of tissue engineered human skin using hpd as biomaterials |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20042556A MY137139A (en) | 2004-06-29 | 2004-06-29 | Formation of tissue engineered human skin using hpd as biomaterials |
Publications (1)
Publication Number | Publication Date |
---|---|
MY137139A true MY137139A (en) | 2008-12-31 |
Family
ID=35782086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20042556A MY137139A (en) | 2004-06-29 | 2004-06-29 | Formation of tissue engineered human skin using hpd as biomaterials |
Country Status (2)
Country | Link |
---|---|
MY (1) | MY137139A (en) |
WO (1) | WO2006001778A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2758208A1 (en) | 2009-04-09 | 2010-10-14 | Jordan Lancaster | Cellular seeding and co-culture of a three dimensional fibroblast construct |
EP2872155A4 (en) | 2012-07-10 | 2016-07-13 | Univ Pennsylvania | Biomaterials for enhanced implant-host integration |
US11338065B2 (en) | 2015-10-08 | 2022-05-24 | Massachusetts Institute Of Technology | In situ expansion of engineered devices for regeneration |
WO2018232323A1 (en) | 2017-06-16 | 2018-12-20 | Avery Therapeutics, Inc. | Three dimensional tissue compositions and methods of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2253724A1 (en) * | 1996-04-26 | 1997-11-06 | Case Western Reserve University | Skin regeneration using mesenchymal stem cells |
DE60126815T2 (en) * | 2000-12-08 | 2007-11-15 | Xgene Corp., San Carlos | PREPARATION OF STORED AND CELL TYPE DRIED WOVEN IN VITRO |
-
2004
- 2004-06-29 MY MYPI20042556A patent/MY137139A/en unknown
-
2005
- 2005-06-24 WO PCT/SG2005/000208 patent/WO2006001778A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2006001778A1 (en) | 2006-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05008406A (en) | Phenylacetamides and their use as glucokinase modulators. | |
MXPA04003487A (en) | Keratinocytes which may be used as biologically active substances for the treatment of wounds. | |
WO2003040346A3 (en) | Methods and compositions for the use of stromal cells to support embryonic and adult stem cells | |
DE60316291D1 (en) | ESTER DERIVATIVES OF HYALURONIC ACID FOR THE PREPARATION OF HYDROGELIC MATERIALS BY PHOTO-PAINTING | |
EP1757315A4 (en) | Biocompatible membrane and process for producing the same | |
WO2005001080A3 (en) | Postpartum-derived cells for use in treatment of disease of the heart and circulatory system | |
WO2007098114A3 (en) | Clotting and healing compositions containing keratin biomaterials | |
WO2010107185A2 (en) | Composition for skin regeneration, containing a secretion in the culture of an embryonic stem cell-derived endothelial progenitor cell or fractions thereof, and use thereof | |
BRPI0822625B8 (en) | modular spacer device for the treatment of prosthetic infections | |
WO2007075981A3 (en) | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures | |
WO2003025149A8 (en) | Cell populations which co-express cd49c and cd90 | |
GEP20146145B (en) | Pharmaceutical composition containing glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process of their preparation and usagetherefor improved glycemic control in patient | |
DE60018044D1 (en) | NEW BIOMATERIALS | |
DE502005010615D1 (en) | MEDICINE FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
DK2195013T3 (en) | Therapeutic use of a growth factor, METRNL | |
MX2009007523A (en) | Silica sol material for producing biologically degradable and/or resorbable silica gel materials, the production and use thereof. | |
ATE466583T1 (en) | VISCOELASTIC SUBSTANCES FOR USE IN MIDDLE EAR SURGERY | |
ATE213164T1 (en) | USE OF NONA- AND DECAPEPTIDES FOR PRODUCING A MEDICINAL PRODUCT TO FIGHT AIDS | |
DE602006016799D1 (en) | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACID OR HYALURONIC ACID DERIVATIVES AND COLLAGENASE FOR THE TOPICAL TREATMENT OF WOUNDS, BURNS AND DISEASES | |
AR032916A1 (en) | ARTIFICIAL DERMIS AND METHOD OF OBTAINING. | |
ATE543519T1 (en) | USE OF A HEMOGLOBIN FOR PRODUCING DRESSES AND DRESSES RESULTING THEREFROM | |
WO2005012492A8 (en) | Human skin equivalents expressing exogenous polypeptides | |
ATE477806T1 (en) | USE OF HYPERBARIC CONDITIONS TO PROVIDE NEUROPROTECTION | |
GB2434105A (en) | Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof | |
HK1106253A1 (en) | Desoxo-nonadepsipeptides |